These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11499261)

  • 1. [Epidemiology and costs of bronchial asthma and chronic bronchitis in Germany].
    Weissflog D; Matthys H; Virchow JC
    Dtsch Med Wochenschr; 2001 Jul; 126(28-29):803-8. PubMed ID: 11499261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Socioeconomic relevance of acute exacerbations of chronic bronchitis in the Federal Republic of Germany. A prospective cost of illness study].
    Rychlik R; Pfeil T; Daniel D; Pfeil B; Mast O; Thate-Waschke I; Lorenz J
    Dtsch Med Wochenschr; 2001 Mar; 126(13):353-9. PubMed ID: 11332229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality, morbidity and costs attributable to smoking in Germany: update and a 10-year comparison.
    Neubauer S; Welte R; Beiche A; Koenig HH; Buesch K; Leidl R
    Tob Control; 2006 Dec; 15(6):464-71. PubMed ID: 17130376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cost-of-illness of asthma in Denmark in the year 2000].
    Mossing R; Nielsen GD
    Ugeskr Laeger; 2003 Jun; 165(26):2646-9. PubMed ID: 12886546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cost of childhood asthma and its determinants in Ankara, Turkey.
    Beyhun NE; Cilingiroğlu N; Sekerel BE
    Turk J Pediatr; 2007; 49(2):179-88. PubMed ID: 17907518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bronchial asthma--a cost of illness analysis].
    Nowak D; Volmer T; Wettengel R
    Pneumologie; 1996 May; 50(5):364-71. PubMed ID: 8710820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment cost of acute exacerbations of chronic bronchitis.
    Niederman MS; McCombs JS; Unger AN; Kumar A; Popovian R
    Clin Ther; 1999 Mar; 21(3):576-91. PubMed ID: 10321424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.
    Simoni-Wastila L; Blanchette CM; Qian J; Yang HW; Zhao L; Zuckerman IH; Pak GH; Silver H; Dalal AA
    Am J Geriatr Pharmacother; 2009 Oct; 7(5):262-70. PubMed ID: 19948302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct and indirect costs of asthma in Canada, 1990.
    Krahn MD; Berka C; Langlois P; Detsky AS
    CMAJ; 1996 Mar; 154(6):821-31. PubMed ID: 8634960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asthma: prevalence and cost of illness.
    Stock S; Redaelli M; Luengen M; Wendland G; Civello D; Lauterbach KW
    Eur Respir J; 2005 Jan; 25(1):47-53. PubMed ID: 15640322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cost of asthma therapy in relation to severity. An empirical study].
    Graf von der Schulenburg JM; Greiner W; Molitor S; Kielhorn A
    Med Klin (Munich); 1996 Oct; 91(10):670-6. PubMed ID: 9019647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes--prevalence and cost of illness in Germany: a study evaluating data from the statutory health insurance in Germany.
    Stock SA; Redaelli M; Wendland G; Civello D; Lauterbach KW
    Diabet Med; 2006 Mar; 23(3):299-305. PubMed ID: 16492214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct medical costs of chronic obstructive pulmonary disease: chronic bronchitis and emphysema.
    Wilson L; Devine EB; So K
    Respir Med; 2000 Mar; 94(3):204-13. PubMed ID: 10783930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Juvenile obesity and comorbidity type 2 diabetes mellitus (T2 DM) in Germany: development and cost-of-illness analysis].
    Wolfenstetter SB
    Gesundheitswesen; 2006 Oct; 68(10):600-12. PubMed ID: 17099820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Epidemiology and costs of lung cancer in Germany].
    Weissflog D; Matthys H; Hasse J; Virchow JC
    Pneumologie; 2001 Jul; 55(7):333-8. PubMed ID: 11481580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The annual impact of seasonal influenza in the US: measuring disease burden and costs.
    Molinari NA; Ortega-Sanchez IR; Messonnier ML; Thompson WW; Wortley PM; Weintraub E; Bridges CB
    Vaccine; 2007 Jun; 25(27):5086-96. PubMed ID: 17544181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in the cost of illness for asthma in the United States, 1985-1994.
    Weiss KB; Sullivan SD; Lyttle CS
    J Allergy Clin Immunol; 2000 Sep; 106(3):493-9. PubMed ID: 10984369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Smoking-attributable productivity loss in Germany--a partial sickness cost study based on the human capital potential method].
    Wegner C; Gutsch A; Hessel F; Wasem J
    Gesundheitswesen; 2004 Jul; 66(7):423-32. PubMed ID: 15314734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Annual direct and indirect health care costs of chronic idiopathic urticaria: a cost analysis of 50 nonimmunosuppressed patients.
    Delong LK; Culler SD; Saini SS; Beck LA; Chen SC
    Arch Dermatol; 2008 Jan; 144(1):35-9. PubMed ID: 18209166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The economic impact of asthma and chronic obstructive pulmonary disease (COPD) in Sweden in 1980 and 1991.
    Jacobson L; Hertzman P; Löfdahl CG; Skoogh BE; Lindgren B
    Respir Med; 2000 Mar; 94(3):247-55. PubMed ID: 10783936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.